Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
-
Novolex and Pactiv Evergreen Inc. to Combine, Establishing a Leading Manufacturer in Food and Beverage Packaging
-
Genius Group adds to its Bitcoin Treasury, with total purchase of 194 Bitcoin for $18 million
-
SaverOne Launches New Pilot Project in Italy with Trans Italia
-
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
-
NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment
-
Tokyo Lifestyle Co., Ltd. to Report First Six Months of Fiscal Year 2025 Financial Results on Wednesday, December 18, 2024
-
Worksport (WKSP) Debuts Innovations Live on National TV Show: Fox & Friends, Outlines Media Strategy for Growing Brand Presence
-
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
-
Monument Announces Updates at the Selinsing Gold Mine and Murchison Gold Project
-
First Hawaiian, Inc. Completes Investment Portfolio Restructuring
-
As the Taylor Swift Eras Tour Ends, a National Study Projects Nearly $7 Billion in Economic Impact Across North America in 2023 and 2024
-
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
-
Vital Farms and Black Seed Bagels Put a Festive Spin on the Bacon, Egg & Cheese: Indulge in the 'Pebble Egg & Cheese' Cocktail at Pebble Bar This Holiday Season
-
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
-
Tsunami Tsolutions and FireSwarm Solutions join forces to field innovative aerial fire suppression technologies
-
Critical Metals Corp Confirms High-Grade Rare Earth Material at Its Tanbreez Project
-
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
-
BetterLife Announces Favorable Outcome in New York Legal Claims
-
Osisko Announces Renewal of Normal Course Issuer Bid
-
LPL Financial Welcomes Financial Advisor Francisco J. Blanco
-
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
-
Graphiant Unveils Revolutionary Data Assurance Offering
-
Oxbridge / SurancePlus Announces Upcoming Participation in Key Industry Events
-
Dayforce Wallet Surpasses $5 Billion Milestone
-
Proposals of the Nomination and Remuneration Committee of Sampo plc’s Board of Directors to the Annual General Meeting
-
Mestag Therapeutics Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform
-
Spryker Achieves AWS Consumer Goods Competency
-
Harvia starts repurchasing own shares for its incentive plan
-
Evaxion announces 2025 milestones reflecting continued strong strategy execution
-
Mark Besca Appointed to Clarus’ Board of Directors
-
$PEDRO COIN Goes Live with Multi-Tier Staking Feature and Detailed Roadmap
-
$PEDRO COIN Goes Live with Multi-Tier Staking Feature and Detailed Roadmap
-
Correction: Prepayments (CK93) - Nykredit Realkredit A/S
-
Namib Minerals and Hennessy Capital Investment Corp. VI Announce Filing of Registration Statement in Connection with their Proposed Business Combination and Namib Minerals’ Planned Nasdaq Listing
-
LeddarTech Enters Into Amendments to Credit Facility and Bridge Financing Offer
-
Lumina Datamatics to acquire controlling stake in TNQTech
-
SL Green Inks 123,000 Square Foot Lease With the Travelers Insurance Company at 485 Lexington Avenue
-
Major shareholder announcement – AIM International Mutual Funds
-
Major shareholder announcement – Invesco Ltd.
-
TDb Split Corp. Class A Share Consolidation
-
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
-
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
-
Aterian’s Mueller Living & PurSteam Brands Launch Three New Products
-
Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017
-
VR Resources Signs MOU with Lac Des Milles Lacs First Nation, Northwestern Ontario
-
Chart Industries to Present at Wells Fargo 23rd Annual Midstream, Energy & Utilities Symposium
-
SL Green Announces Transactions at 100 Park Avenue
-
Aterian’s Mueller Living & PurSteam Brands Launch Three New Products
-
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference


